Stocks
Zynerba Pharmaceuticals (ZYNE) EV/EBITDA US GAAP (year values) |
||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | |||
| EV/EBITDA | ? | 0.35 | -1.85 | -0.58 | -1.27 | 0.80 | -0.77 | |
| Changes by years, y/y, % | -111% | -622% | -69% | +119% | -163% | |||
Zynerba Pharmaceuticals. EV/EBITDA
Zynerba Pharmaceuticals. EV/EBITDA, changes, %
Zynerba Pharmaceuticals (ZYNE) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
| EV/EBITDA | ? | 0.40 | 0.68 | 0.76 | 0.64 | 0.51 | -0.77 | |
| Changes by years, y/y, % | -112% | -127% | -157% | -278% | +26% | |||
| Changes by quarters, q/q, % | -212% | +68% | +12% | -16% | -21% | |||
